14 September 2016 EMA/730861/2016 Procedure Management and Committees Support

List of nationally authorised medicinal products

Active substance: testosterone (all formulations apart from topical use and testosterone undecanoate injection)

Procedure no.: PSUSA/00002907/201512

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged.

Product Name (in authorisation country) Andriol Andriol

MRP/DCP Authorisation number

National Authorisation Number 024585010 $ 024585034 1-19756

MAH of product in the member state Msd Italia S.R.L.

Member State where product is authorised Italy

Nv Organon

Austria

Andriol

6598

Nv Organon

Norway

Andriol

9264

Nv Organon

Denmark

Andriol Testocaps

OGYI-T-9405/01 $ OGYI-T-9405/02 $ OGYI-T-9405/03 RVG 07531

Nv Organon

Hungary

Nv Organon

Netherlands

Merck Sharp & Dohme, Lda.

Portugal

Androtardyl

4147989 $ 4781183 $ 4781282 34 009 300 461 3 5

Bayer Healthcare

France

Panteston

7845

Nv Organon

Finland

Panteston

7845

Nv Organon

Finland

Pantestone

Msd France

France

Nv Organon

Greece

Restandol Testocaps

34009 377 647 4 2 $ 34009 377 648 0 3 $ 34009 379 817 43 41177/10/31-052011 PA 1286/54/1

Ireland

Restandol Testocaps

PL 00025/0595

Merck Sharp & Dohme Ireland (Human Health) Ltd Merck Sharp & Dohme Ltd.

Sustanon

016094017

Trading

Italy

Sustanon

211498

Trading

Estonia

Sustanon

3811

Trading

Finland

Sustanon

56/0357/91-C/S

Trading

Slovakia

Sustanon

97-0497

Aspen Pharma Limited Aspen Pharma Limited Aspen Pharma Limited Aspen Pharma Limited Aspen Pharma

Trading

Latvia

Andriol Testocaps Andriol-T

Restandol Testocaps

List of nationally authorised medicinal products EMA/730861/2016

United Kingdom

Page 2/4

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

Sustanon

BE 012704

Sustanon

LT/1/97/1261/003

Sustanon

PL 39699/0059

Sustanon '250'

BE 012704

Sustanon 250

56/357/91-C

Sustanon ‘250’

BE 012704

Sustenon

8890012

Testocaps

2007079379

Testocaps

BE 113793 $ BE113793 PL 16853/0116

MAH of product in the member state Limited Aspen Pharma Limited Aspen Pharma Limited Aspen Pharma Limited Aspen Pharma Limited Aspen Pharma Limited Aspen Pharma Limited Aspen Pharma Limited Nv Organon

Member State where product is authorised

Trading

Luxembourg

Trading

Lithuania

Trading

United Kingdom

Trading

Belgium

Trading

Czech Republic

Trading

Belgium

Trading

Portugal Luxembourg

Nv Organon

Belgium United Kingdom

002922060

Alliance Pharmaceuticals Ltd Bayer Spa

Testoviron Depot

8888222

Bayer Portugal Sa

Portugal

Testoviron-Depot

6929279.00.00

Jenapharm Gmbh & Co Kg

Germany

Testovis

003559059

Italy

Undestor

56/023/91-S/C

Laboratorio Farmaceutico S.I.T. S.R.L. Nv Organon

Undestor Testocaps

Nv Organon

Romania

Undestor Testocaps

1076/2008/01 $ 1076/2008/02 $ 1076/2008/03 56/0091/03-S

Nv Organon

Slovakia

Undestor Testocaps

9559

Merck Sharp & Dohme Bv

Sweden

Undestor Testocaps

R/2344

Nv Organon

Poland

Testosterone Enantate Alliance Pharmaceuticals Testoviron

List of nationally authorised medicinal products EMA/730861/2015

Italy

Czech Republic

Page 3/4

Product Name (in authorisation country) Virormone

List of nationally authorised medicinal products EMA/730861/2015

MRP/DCP Authorisation number

National Authorisation Number PL00111/0203

MAH of product in the member state Dhp Healthcare Ltd

Member State where product is authorised United Kingdom

Page 4/4

testosterone - European Medicines Agency - Europa EU

Sep 14, 2016 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of ... Procedure Management and Committees Support.

80KB Sizes 12 Downloads 240 Views

Recommend Documents

Testosterone undecanoate - European Medicines Agency - Europa EU
Sep 14, 2016 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom ... Procedure Management and Committees Support. List of ...

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Eleclazine - European Medicines Agency - Europa EU
Feb 9, 2017 - Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply).

July 2017 - European Medicines Agency - Europa EU
Jul 5, 2017 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

SME Office - European Medicines Agency - Europa EU
maximises the chances of a successful marketing authorisation. ... marketing authorisation. • inclusion in the public SME ... E-mail [email protected]. Website ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Action plan - European Medicines Agency - Europa EU
5 days ago - Guidelines should include more details on the principles of good information design in which content and layout are ... relevance and importance of the QRD template is also acknowledged in this respect as it is the main tool .... databas

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - Add an existing Tag to a specific Term . ...... This service creates an email body (text/html) of a user's notification data, a notification is based on.

ATMP - European Medicines Agency - Europa EU
Nov 24, 2017 - E8. 09/08/2017. 10/08/2017. 24/08/2017 17/08/2017 22/08/2017. 24/08/2017. 30/08/2017. 01/09/2017. 04/09/2017. 08/09/2017. 14/09/2017.

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Evofosfamide - European Medicines Agency - Europa EU
Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply). (possible) lack of ...

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

minoxidil - European Medicines Agency - Europa EU
Jun 14, 2018 - Page 2/26. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the.

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för

latanoprost - European Medicines Agency - Europa EU
May 13, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ..... Xaloptic Free. NL/H/3193/001.

Cyproterone/ethinylestradiol - European Medicines Agency - Europa EU
March 2016 a joint database drug utilisation final study report to the European .... With regards to prescription of CPA/EE for contraceptive management, ...

ganciclovir - European Medicines Agency - Europa EU
Feb 9, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. 20010180.

July 2016 - European Medicines Agency - Europa EU
For a list of RSS readers please refer to our RSS guide and follow the instructions ..... PCWP and HCPWP joint meeting: Workshop on social media - Sep 2016.